Antibody-directed cell-type-specific delivery of siRNA. Vornlocher HP. Trends Mol Med.2006 Jan;12(1):1-3. Epub 2005 Nov 14. View Abstract on PubMed

Nucleic acid complexing glycosyl nucleoside-based amphiphile. Arigon J, Prata CA, Grinstaff MW, Barthélémy P. Bioconjug Chem. 2005 Jul-Aug;16(4):864-72. View Abstract on PubMed

Supramolecular assemblies of DNA with neutral nucleoside amphiphiles. Barthelemy P, Prata CA, Filocamo SF, Immoos CE, Maynor BW, Hashmi SA, Lee SJ,
Grinstaff MW. Chem Commun (Camb). 2005 Mar 14;(10):1261-3. Epub 2005 Jan 21. View Abstract on PubMed

Nucleoside phosphocholine amphiphile for in vitro DNA transfection. Moreau L, Barthélémy P, Li Y, Luo D, Prata CA, Grinstaff MW. Mol Biosyst. 2005 Sep;1(3):260-4. Epub 2005 Jul 22. View Abstract on PubMed

Dendritic supramolecular assemblies for drug delivery. Morgan MT, Carnahan MA, Finkelstein S, Prata CA, Degoricija L, Lee SJ, Grinstaff MW. Chem Commun (Camb). 2005 Sep 14;(34):4309-11. Epub 2005 Jul 14. View Abstract on PubMed

Targeting MLL-AF4 with short interfering RNAs inhibits clonogenicity and engraftment of t(4;11)-positive human leukemic cells. Thomas M, Gessner A, Vornlocher HP, Hadwiger P, Greil J, Heidenreich O. Blood. 2005 Nov 15;106(10):3559-66. Epub 2005 Jul 26. View Abstract on PubMed

RNA interference in vivo: toward synthetic small inhibitory RNA-based therapeutics. de Fougerolles A, Manoharan M, Meyers R, Vornlocher HP. Methods Enzymol. 2005;392:278-96.View Abstract on PubMed

Chemical modifications to achieve increased stability and sensitive detection of siRNA.Hadwiger P, and Vornlocher HP. In: RNA Interference: From Basic Science to Drug Development (K. Appasani, ed.), Cambridge University Press, Cambridge. 2005; 194-206.View Book Summary

Gene silencing methods for mammalian cells: application of synthetic short interfering RNAs. John M, Geick A, Hadwiger P, Vornlocher HP, Heidenreich O. Handbook of RNA Biochemistry. 2005; 897-909. View Book Summary